Clinical-economic impact of the change of protocol for use of basiliximab in liver transplant
Objective: Evaluation of the clinical and economic impact after the protocol change of basiliximab use in orthohepatic transplant. Method: Retrospective study in which all liver transplant patients were included during the years 2013, 2014 and until February 15, 2015. The study was divided into t...
Main Authors: | Enrique Tévar-Alfonso, Inmaculada Plasencia-García, Antonio González- Rodríguez, Antonia Moreno-García, Javier Merino-Alonso, Armando Aguirre- Jaime |
---|---|
Format: | Article |
Language: | English |
Published: |
Grupo Aula Médica
2019-01-01
|
Series: | Farmacia Hospitalaria |
Subjects: | |
Online Access: | http://www.aulamedica.es/fh/pdf/11036.pdf |
Similar Items
-
Efficacy of basiliximab induction in poorly matched living donor renal transplantation
by: S Gundlapalli, et al.
Published: (2013-01-01) -
Efficacy and safety of basiliximab as initial immunosuppression in liver transplantation: A single center study
by: Mohamed Hashim, et al.
Published: (2020-09-01) -
Basiliximab induction in living donor kidney transplant with tacrolimus-based triple immunosuppression
by: Shyam Bihari Bansal, et al.
Published: (2019-01-01) -
Fatal anaphylactic reaction due to Basiliximab
by: Patricia Lovisolo, et al.
Published: (2017-04-01) -
Outcome Comparison between Low-Dose Rabbit Anti-Thymocyte Globulin and Basiliximab in Low-Risk Living Donor Kidney Transplantation
by: Sang Jin Kim, et al.
Published: (2020-05-01)